Literature DB >> 4616018

Transfer factor in cellular immunity.

H S Lawrence.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4616018

Source DB:  PubMed          Journal:  Harvey Lect        ISSN: 0073-0874


× No keyword cloud information.
  11 in total

1.  A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

Authors:  R C Collins; L R Espinoza; C R Plank; G C Ebers; R A Rosenberg; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?

Authors:  I L Sargent; M R Salaman
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

3.  Crude transfer-factor preparations stimulate trypsinized human lymphocytes to form rosettes with sheep red cells.

Authors:  H Valdimarsson; R L McGuire
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

4.  Evidence for the presence of a low molecular-weight activator of suppressor monocytes (LASM) in dialysates of T lymphocytes.

Authors:  K Nekam; A J Strelkauskas; H H Fudenberg; G G Donnan; J M Goust
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

5.  Immunocompetence and transfer factor therapy in uveitis.

Authors:  A Abramson; A Khan; G W Tate; R G Martin; N O Hill
Journal:  Br J Ophthalmol       Date:  1980-05       Impact factor: 4.638

6.  A placebo controlled clinical trial of transfer factor in lepromatous leprosy.

Authors:  W R Faber; D L Leiker; I M Nengerman; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.

Authors:  R G Ashorn; L Räsänen; K M Marnela; K J Krohn
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

8.  In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response.

Authors:  A A Gottlieb; S B Sutcliffe
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

9.  Susceptibility of murine transfer factor to dimerized ribonuclease A.

Authors:  D Rifkind; J A Frey; M Dinowitz
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates.

Authors:  L Cohen; R S Holzman; F T Valentine; H S Lawrence
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.